SCHEMBL17295402

SCHEMBL17295402

Cc1ccc(N=C2SC(=Cc3ccc4c(cnn4C)c3)C(=O)N2CC(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ MAPT P10636 3/20 0.49
▸ NPSR1 Q6W5P4 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CA9 Q16790 3/20 0.47
▸ POLB P06746 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ FAAH O00519 2/20 0.41
▸ CLK1 P49759 2/20 0.41
▸ DYRK1A Q13627 2/20 0.41
▸ CLK4 Q9HAZ1 2/20 0.41
▸ DYRK1B Q9Y463 2/20 0.41
▸ AURKA O14965 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295401 1.00 ALDH1A1 (0.49) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL17295633 0.81 FAAH (0.53) ALDH1A1MAPTKMT2ACA9POLB
SCHEMBL17295634 0.81 FAAH (0.53) ALDH1A1MAPTKMT2ACA9POLB
SCHEMBL17295605 0.80 FAAH (0.55) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL17295607 0.80 FAAH (0.55) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL17295299 0.78 ALDH1A1 (0.50) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL17295297 0.78 ALDH1A1 (0.50) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL17295407 0.77 CA9 (0.52) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL17295404 0.77 CA9 (0.52) ALDH1A1MAPTNPSR1MEN1KMT2A
SCHEMBL19096572 0.77 ALDH1A1 (0.48) ALDH1A1MAPTNPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback